| |
 |
 |
|
 |
 |
|
26-28 January 2006
8th International Symposium on Febrile Neutropenia
Athens,
Greece • Athens Ledra Marriott Hotel
Chair:
Jean A. Klastersky, MD, PhD
Jules Bordet Institute
Brussels, Belgium
Local
Chairs:
George L. Petrikkos, MD
National and Kapodistrian University of Athens,
Medical School, Athens, Greece
Helen
Giamarellou, MD, PhD
National and Kapodistrian University of Athens,
Medical School, Athens, Greece
Click
here to register for this program |
 |
|
I N T E R N A T I O N A L A D
V I S O R Y C O M M
I T T E E |
 |
|
| J.
Peter Donnelly, PhD
Radboud University Nijmegen
Nijmegen, The Netherlands
Kenneth
V. I. Rolston, MD
MD Anderson Cancer Center
Houston, Texas, United States |
Miguel
A. Sanz, MD
University Hospital La Fe
Valencia, Spain
Martin
Tattersall, MD
University of Sydney
Sydney, Australia |
John
R. Wingard, MD
University of Florida
Gainesville, Florida, United States |
|
|
|
L O C A L S C I E N T I F I C C
O M M I T T E E (
G R E E C E ) |
|
|
| Georgios
Anagnostopoulos
Kostas
Bourantas
Ioannis
Christakis
George
L. Daikos
Athanasios
Demopoulos
Ioannis Dervenoulas
Anna
Efremidou |
Athanasios
Fassas
Vasilios
Georgoulias
Emmanouel
Nikiforakis
Theophanis
Oikonomopoulos
Panagiotis Panagiotides
Gerasimos Pangalis |
Nikolaos
Pavlides
Emmanouel
Roilides
George Samonis
Vasilios
Seitanides
Athanasios
Skoutelis
Nikolaos
Stathakis
Nikolaos Zoubos |
|
|
|
F A C U L T Y |
|
|
| Murat
Acova, MD
Hacettepe University School of Medicine
Ankara, Turkey
Anastasia
Antoniadou, MD
National and Kapodistrain University of
Athens Medical School
Athens, Greece
Nicole
M.A. Blijlevens, MD, PhD
Radboud University Nijmegen
Nijmegen, The Netherlands
Ben
E. de Pauw, MD
Radboud University Nijmegen
Nijmegen, The Netherlands
George
L. Daikos, MD
National and Kapodistrain University of
Athens Medical School
Athens, Greece
Javier
de la Rubia, MD
University Hospital La Fe
Valencia, Spain
J.
Peter Donnelly, PhD
Radboud University Nijmegen
Nijmegen, The Netherlands
Joel
B. Epstein, DMD, MSD, FRCD(C)
University of Illinois at Chicago
Chicago, Illinois, United States
|
Ronald
Feld, BSc, MD, FRCPC, FACP
Princess Margaret Hospital
Toronto, Canada
Marie-Thérése
Genot, MD
Institute Jules Bordet
Brussels, Belgium
Richard
G. Jenner, MD
Whitehead Institutee for Biomedical Research
Cambridge, Massachusetts, United States
Jean
A. Klastersky, MD, PhD
Institutee Jules Bordet
Brussels, Belgium
Helen
Giamarellou, MD, PhD
Sismanoglio General Hospital
Athens, Greece
Kieren
A. Marr, MD
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Georg
Maschmeyer, MD
Klinikum Ernst von Bergmann
Postdam, Germany
Francesco
Menichetti, MD
Ospedale Cisanello
Pisa, Italy
Gerasimos
Pangalis, MD
National and Kapodistrain University of
Athens Medical School
Athens, Greece
|
Marianne
Peasmans, MSc
Jules Bordet Institutee
Brussels, Belgium
George
L. Petrikkos, MD
National and Kapodistrain University of
Athens Medical School
Athens, Greece
Emmanouel
Roilides, MD
Hippocration Hospital
Thessaloniki, Greece
Kenneth
V.I. Rolston, MD
MD Anderson Cancer Center
Houston, Texas, United States
George
Samonis, MD
University Hospital Heraklion
Crete, Greece
Miguel
A. Sanz, MD
Hospital Universitario La Fe
Valencia, Spain
Martin
Tattersall, MD
University of Sydney
Sydney, Australia
John
R. Wingard, MD
University of Florida
Gainesville, Florida, United States
|
|
|
|
S C I E N T I F I C A G E N D A |
|
|
| Thursday,
26 January 2006 12:00
Introduction and Welcome
Jean A. Klastersky, MD, PhD
George L. Petrikkos, MD
Helen Giamarellou, MD, PhD
Session
I Etiologic Factors, Diagnosis, and Prognostic
Implications in Febrile Neutropenia
Co-Chairs:
Martin Tattersall, MD, University of Sydney,
Sydney, Australia
Vasilios Seitanides, MD, Hygeia Medical
International Hospital, Athens, Greece
George L. Daikos, MD, National and Kapodistrian
University of Athens, Medical School, Athens,
Greece
12:10
The duration of neutropenia
Marianne Paesmans, MSc, Jules Bordet Institute,
Brussels, Belgium
12:45
Newer diagnostic markers in febrile neutropenia
Anastasia Antoniadou, MD, National and Kapodistrian
University of Athens, Medical School, Athens,
Greece
13:20
Poster #1
13:30
Poster #2
13:40
Panel Discussion
14:00
Break
Session II Management of Fungal Infections
in Febrile Neutropenia
Co-Chairs:
Jean A. Klastersky, MD, PhD, Jules Bordet
Institute, Brussels, Belgium
George L. Petrikkos, MD, National and Kapodistrian
University of Athens, Medical School, Athens,
Greece
Marianne Peasmans, MSc, Jules Bordet Institute,
Brussels, Belgium
14:20
Important pathogens and impact of emerging
resistant strains
John R. Wingard, MD, University of Florida,
Gainesville, Florida, United States
14:55
Criteria to choose the most appropriate
antifungal agents in febrile neutropenic
patients
George L. Petrikkos, MD, National and Kapodistrian
University of Athens, Medical School, Athens,
Greece
16:30
Poster #1
16:40
Poster #2
16:50
Panel Discussion
17:10
Adjourn
Friday, 27 January 2006
08:30
Keynote Address: Outpatient therapy of febrile
neutropenia in 2006
Ronald Feld, BSc, MD, FRCPC, FACP, Princess
Margaret Hospital, Toronto, Canada
Session
III Bacterial Infections in Febrile Neutropenia:
Antibiotic Therapy and Management of Resistance
Co-Chairs:
Kenneth V.I. Rolston, MD, MD Anderson Cancer
Center, Houston, Texas
Helen Giamarellou, MD, PhD, National and
Kapodistrian University of Athens, Medical
School, Athens, Greece
Ronald Feld, BSc, MD, FRCPC, FACP, Princess
Margaret Hospital, Toronto, Ontario, Canada
09:15
Experience in the treatment of multiresistant
bacteria
Helen Giamarellou, MD, National and Kapodistrian
University of Athens, Medical School, Athens,
Greece
09:50
New antibiotics to be used in febrile neutropenic
patients in the next 10 years
Kenneth V.I. Rolston, MD, MD Anderson Cancer
Center, Houston, Texas, United States
10:25
Poster #1
10:35
Poster #2
10:45
Panel Discussion
11:05
Keynote Address: DNA microarrays in infectious
disease
Richard G. Jenner, MD, Whitehead Institute
for Biomedical Research, Cambridge, Massachusetts
12:00
Lunch
Session
IV Mucositis in Febrile Neutropenia
Co-Chairs:
J. Peter Donnelly, PhD, Radboud University
Nijmegen, Nijmegen, The Netherlands
George Samonis, MD, University Hospital
of Heraklion, Crete, Greece
Marie Therese Genot, MD, Brussels, Belgium
13:30
Biological aspects of mucositis
Joel B. Epstein, DMD, MSD, FRCD(C), University
of Illinois at Chicago, Chicago, Illinois,
United States
14:05
The relationship between fever, neutropenia,
infection and mucositis
Nicole M.A. Blijlevens MD, PhD, Radboud
University Nijmegen, Nijmegen, The Netherlands
14:40
Poster #1
14:50
Poster #2
15:00
Panel Discussion
15:20
Break
Session
V Growth Factors and Blood Transfusion
Co-Chairs:
Miguel A. Sanz, MD, University Hospital
La Fe, Valencia, Spain
Emmanouel Roilides, MD, Hippocration Hospital,
Thessaloniki, Greece
John R. Wingard, MD, University of Florida,
Gainesville, Florida, United States
15:40
Growth factors in the supportive therapy
of febrile neutropenic patients with cancer
Miguel A. Sanz, MD, University Hospital
La Fe, Valencia, Spain
16:15
Granulocyte transfusion for neutropenia-related
infections
Javier de la Rubia, MD, University Hospital
La Fe, Valencia, Spain
16:50
Poster #1
17:00
Poster #2
17:10
Panel Discussion
17:30
Adjourn
Saturday,
28 January 2006
Session
VI Challenging Cases in Febrile Neutropenia
Moderator: Ben E. de Pauw, MD, Radboud University
Nijmegen, Nijmegen, The Netherlands
Presenter: J. Peter Donnelly, PhD, Radboud
University Nijmegen, Nijmegen, The Netherlands
Case Contributors: Murat Acova, MD, Hacettepe
University School of Medicine, Ankara, Turkey
and Francesco Menichetti, MD, Ospedale Cisanello,
Pisa, Italy
Expert Panel: George L. Daikos, MD, National
and Kapodistrian University of Athens, Medical
School, Athens, Greece; Emmanouel Roilides,
MD, Hippocration Hospital, Thessaloniki,
Greece
08:30
Case presentations and discussion
Session VII Evolution in Onco-Hematological
Therapies
Co-Chairs:
John R. Wingard, MD, University of Florida,
Gainesville, Florida, United States
Gerasimos Pangalis, MD, National and Kapodistrian
University of Athens, Medical School, Athens,
Greece
Martin Tattersall, MD, University of Sydney,
Sydney, Australia
09:30
Changing treatment paradigms in hematologic
malignancies and their impact on infectious
complications
Georg Maschmeyer, MD, Klinikum Ernst von
Bergmann, Potsdam, Germany
10:00
New hematopoietic transplant practices and
the changing face of infectious risks
Kieren A. Marr, MD, Fred Hutchinson Cancer
Center, Seattle, Washington, United States
10:30
Poster #1
10:40
Poster #2
10:50
Panel Discussion
11:10
Break
Session
VIII 2006 Consensus on Management of Febrile
Neutropenia and 2007 Plans
11:30
Roundtable discussion with International
Advisory Committee
Summary of 2006 Conference
12:00
Roundtable discussion with International
Advisory Committee
Announcement of 2007 Conference and plans
for 2007 agenda
12:25
Audience participation
13:00
Adjourn |
|
|
|
I N V I T A T I O N |
|
|
Dear
Colleague:
It
is our distinct pleasure to announce the
8th International Symposium on Febrile Neutropenia,
to be held 26-28 January 2006 in Athens,
Greece.
Over
the past several years, this conference
has grown into a prominent forum for discussion
of current knowledge on the etiology, diagnosis,
and state-of-the-art management of febrile
neutropenia. We have gathered high-caliber,
world-renowned experts in the fields of
infectious disease, immunology, hematology
and oncology to discuss a mélange
of topics relevant to our field in both
didactic and case-based presentations.
This
year, we are particularly excited to hold
the Symposium in Athens, Greece, undoubtedly
one of the great centers of art, culture
and science in the world. We are grateful
to our hosts for helping us organize a program
which will be not only professionally, but
also culturally enlightening. The rich history
and local flavor of this city make for a
perfect setting for our conference, and
will ensure a truly enjoyable experience.
We
sincerely hope you can join us in Athens
and help contribute to the growing success
of our Symposium.
Sincerely,
Jean
A. Klastersky, MD, PhD
Helen Giamarellou, MD, PhD
George A. Pettrikkos, MD
|
|
|
|
C O N F E R E N C E A C C R E D I T
A T I O N |
|
|
| This
conference has been approved by ESMO for
16 ESMO MORA category 1 points. Participants
will receive a certificate of attendance
with their conference registration. |
|
|
|
W H O S H O U L D A T T E N D
? |
|
|
| This
educational program is specifically designed
for medical oncologists, infectious disease
specialists, radiation oncologists, and
other physicians, physicians-in-training,
and healthcare professionals (nurses, pharmacists)
interested in and/or involved in the care
of patients with febrile neutropenia. No
specialized knowledge or skill other than
general familiarity with the above disciplines
is required for successful participation
in this program. |
|
|
|
E D U C A T I O N A L O B J E C T I
V E S |
|
|
| After
completion of this activity, participants
should be able to:
-
Review important etiologic factors contributing
to the development of febrile neutropenia,
and advances in the diagnosis of this
disorder
-
Identify important fungal and bacterial
pathogens causing infection in febrile
neutropenic patients
-
Discuss recent progress in the management
of infection in febrile neutropenic patients
-
Understand biological aspects and implications
of mucositis in febrile neutropenic patients
-
Identify and manage key supportive care
issues in patients with febrile neutropenia
|
|
|
|
|
R E G I S T R A T I O N |
|
|
| Click
here to register for this program
REGISTRATION
FEES
Regular: € 625
If payment received by 16 January 2006
Full:
€ 695
If payment received after 16 January 2006
Nurses/Residents/Students*:
€ 200
*proof of eligibility must accompany registration
ESMO
Membership*: –€ 50
*proof of eligibility must accompany registration
To
Register: You may register on-line
or call Imedex at +1 (770) 751 7332. Registration
confirmations will be issued before the
meeting. Registration is not complete without
payment.
To
qualify for special registration fees, registration
and full payment must be received by Imedex
by the dates specified.
Payment:
Registration fees and hotel reservation
guarantees can be remitted by credit card,
check, or wire transfer. Checks should be
payable to Imedex. To pay via wire transfer,
you must add €50 to the registration
fee to cover bank charges. Include the full
name of the attendee and the name of the
conference: Febrile Neutropenia #239. Attendee
is not registered until full payment is
received.
Wire
to: Bank of America NA London, Swift Code:
BOFAGB22, Sort Code: 16-50-50,
IBAN: GB89 BOFA 1650 5095 6870 29, Beneficiary:
Bank of America Domestic Deposit 5687, Account#
600895687029, Reference: Imedex, Inc. Account#
10726-118.
Registration
Fee Inclusions: Registration fees include
admittance to scientific sessions, conference
materials and all functions as specified
in the program.
Cancellation:
For registration fees to be refunded, written
notice of cancellation must be received
at Imedex by 19 January 2006. The amount
of registration fees remitted, minus a €90
administrative charge, will be refunded
after the conference. Substitutions are
accepted with written notification. After
19 January 2006 no refunds will be made.
Imedex
does not accept responsibility for covering
travel, accommodation or any other costs
incurred by registrants in the rare event
that this program should be cancelled for
any reason. Every effort will be made to
give reasonable notice in the event of cancellation.
The event program content is subject to
change without notice. |
|
|
|
H O T E L A C
C O M M O D A T I O N S |
|
|
| Athens
Ledra Marriott Hotel
115 Syngrou Avenue
11745 Athens, Greece
Tel.: 30 (210) 930 0000
Fax: 30 (210) 935 8603
Welcome
to Athens, a place where the ancient and
the modern effortlessly mingle on a sun-washed
coastline. The newly renovated Athens Ledra
Marriott Hotel is located in the heart of
the business district, only ten minutes
from the City Centre and the Acropolis and
fifteen minutes from the Port of Piraeus.
You can relax on the roof top pool and enjoy
a bird’s eye view of Athens and the
Acropolis. Newly renovated guest rooms surround
guests with a stylish, yet ergonomic setting.
For
the convenience of attendees, a limited
number of rooms has been reserved at a rate
of €140 for single occupancy and €150
for double occupancy. This price includes
all local taxes and an American buffet breakfast.
This rate is not guaranteed outside the
conference dates, and you must book your
room through the conference secretariat
to receive this special discount.
For
individual reservations, please submit a
completed hotel reservation form. For group
hotel reservations, groups should contact
Imedex directly. Imedex will attempt to
meet all accommodation requests, however
it reserves the right to change the requested
hotel to one of a similar category if unable
to confirm the hotel described in this brochure.
PLEASE
NOTE:
- Full
pre-payment for your hotel reservation
is due upon booking your reservation.
- Any
cancellations made within 13 calendar
days prior to arrival will be charged
the entire stay to the individual’s
credit card.
- Individuals
in absentia will be charged the full amount
on the individual’s credit card.
- Early
departures will be charged the full amount
of the original reservation on the individual’s
credit card.
|
|
|
|
G E N E R A L I N F O R M A T I O N |
|
|
|
DISCOUNTED AIRFARES
Contact conference travel agent, Age of
Travel, for assistance with our travel needs.
Age of Travel can also accommodate pre-
and post-conference extensions.
Tel.: +1 (800) 523 4954 or +1 (404) 591
7120
Email: Imedex@ageoftravel.com
ITALIAN
PARTICIPANTS
Fargo International Meetings and Conventions
SrI has been appointed as the official agency
for government authorization for Italian
participants. You may contact them directly
at: Via Piattro Maroncelli 44/46, 50137
Firenze Italy, Tel: +39 055 609 078, Fax:
+39 055 600 555.
CONFERENCE
LOCATION AND REGISTRATION HOURS
Athens Ledra Marriott Hotel
115 Syngrou Ave.
11745 Athens, Greece
Tel.: 30 (210) 930 0000
Fax: 30 (210) 935 8603
The
Registration and Information Desk will be
staffed:
Thursday
26 January . . . . . . . . 10.00 –
20.00
Friday 27 January . . . . . . . . 07.30
– 18.00
Saturday 28 January . . . . . . . . 07.30
– 12.30
|
|
|
|
O R G A N I Z E R |
|
|
|
| |
|
|
|
| |
|
|
| ©
2005 Imedex®, Inc |
|
|
|
